Our results showed that each tumor carried mutations in at least one well-known TSG/oncogene or predicted TSG/oncogene, such as p53, Kras, and Nras, and many tumors carried more than one (Fig. 2a; Table 1). This evidence concerns the gene KRAS and neoplasm.